The Institute of Cancer Research ( ICR ) is planning a £ 75 m ( $ 96 m ) state - of - the - art facility to develop drugs that can stimulate tumours resisting aging by slowing down cancer 's ability to reproduce . Scientists will also plan to combine drugs to boost the immune system and activate several cancer genes at once . ICR has so far raised £ 60 m towards the cost of the London - based facility .
The Institute of Cancer Research (ICR) is planning a £75m ($96m) state-of-the-art facility to develop drugs that can stop tumours resisting treatment by slowing down cancer's ability to evolve. Scientists will also seek to combine drugs to boost the immune system and block several cancer genes at once. ICR has so far raised £60m towards the cost of the London-based facility.